INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,540 | +67.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $11,060 | -17.6% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $13,430 | +11.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $12,000 | -14.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -12.5% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $16,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | +6.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $15,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -13.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $23,000 | -8.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -39.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $41,000 | -14.6% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $48,000 | -23.8% | 1,000 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $63,000 | -49.2% | 1,000 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $124,000 | +87.9% | 1,000 | 0.0% | 0.01% | +66.7% |
| Q3 2019 | $66,000 | -17.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $80,000 | -11.1% | 1,000 | -35.4% | 0.00% | 0.0% |
| Q3 2017 | $90,000 | -54.8% | 1,549 | -11.9% | 0.00% | -57.1% |
| Q1 2017 | $199,000 | -42.8% | 1,759 | -27.8% | 0.01% | -30.0% |
| Q2 2016 | $348,000 | -24.5% | 2,436 | -32.1% | 0.01% | -28.6% |
| Q1 2016 | $461,000 | +4090.9% | 3,587 | +8867.5% | 0.01% | – |
| Q1 2015 | $11,000 | +83.3% | 40 | 0.0% | 0.00% | – |
| Q4 2014 | $6,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |